HeartSciences Income from Continuous Operations 2022-2025 | HSCS

HeartSciences income from continuous operations from 2022 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
HeartSciences Annual Income from Continuous Operations
(Millions of US $)
2024 $-7
2023 $-6
2022 $-5
2021 $-2
HeartSciences Quarterly Income from Continuous Operations
(Millions of US $)
2025-01-31 $-3
2024-10-31 $-2
2024-07-31 $-2
2024-04-30 $-2
2024-01-31 $-2
2023-10-31 $-2
2023-07-31 $-1
2023-04-30 $-2
2023-01-31 $-1
2022-10-31 $-2
2022-07-31 $-2
2022-04-30 $-2
2022-01-31 $-1
2021-10-31 $-1
2021-07-31 $-1
2021-04-30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.005B $0.000B
Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.177B 57.48
Doximity (DOCS) United States $11.570B 53.56
Hims & Hers Health (HIMS) United States $11.189B 116.26
Tempus AI (TEM) United States $10.500B 0.00
IRhythm Technologies (IRTC) United States $4.334B 0.00
Inspire Medical Systems (INSP) United States $3.774B 58.97
Hinge Health (HNGE) United States $3.628B 0.00
Privia Health (PRVA) United States $2.525B 172.58
Enovis (ENOV) United States $1.763B 9.83
Schrodinger (SDGR) United States $1.589B 0.00
Phreesia (PHR) United States $1.543B 0.00
10x Genomics (TXG) United States $1.533B 0.00
Clover Health Investments (CLOV) United States $1.532B 0.00
Azenta (AZTA) United States $1.470B 68.32
Evolent Health (EVH) United States $1.323B 112.70
Omnicell (OMCL) United States $1.310B 23.12
Claritev (CTEV) United States $0.733B 0.00
Fulgent Genetics (FLGT) United States $0.552B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.475B 0.00
Butterfly Network (BFLY) United States $0.457B 0.00
Talkspace (TALK) United States $0.422B 126.00
TruBridge (TBRG) United States $0.328B 728.33
Outset Medical (OM) United States $0.312B 0.00
Nyxoah SA (NYXH) Belgium $0.282B 0.00
Health Catalyst (HCAT) United States $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.250B 0.00
CapsoVision (CV) United States $0.218B 0.00
Zepp Health (ZEPP) Netherlands $0.206B 0.00
KORU Medical Systems (KRMD) United States $0.152B 0.00
American Well (AMWL) United States $0.126B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.107B 0.00
CareCloud (CCLD) United States $0.105B 3.98
Insight Molecular Diagnostics (IMDX) United States $0.081B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.080B 0.00
111 (YI) China $0.065B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00